MARKETSDr. Reddy’s Signs Licensing Deal with Gilead to Commercialise HIV Drug, Shares Trading FlatDhruva KulkarniOctober 3, 2024October 3, 2024 October 3, 2024October 3, 2024 Shares of Dr. Reddy’s Laboratories Ltd. are trading flat after touching a day’s high of Rs 6,795 on 3rd October. This follows the firm’s announcement...